Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine

Xiaolan Yong, Jun Liu, Ying Zeng, Jing Nie, Xuelian Cui, Tao Wang, Yilin Wang, Yiyong Chen, Wei Kang, Zhonghua Yang, Yan Liu
doi: https://doi.org/10.1101/2023.07.17.23292762

Data Availability

The data used in the current study are available from the corresponding authors upon reasonable request.

Back to top
Posted July 18, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
Xiaolan Yong, Jun Liu, Ying Zeng, Jing Nie, Xuelian Cui, Tao Wang, Yilin Wang, Yiyong Chen, Wei Kang, Zhonghua Yang, Yan Liu
medRxiv 2023.07.17.23292762; doi: https://doi.org/10.1101/2023.07.17.23292762
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area